Cargando…

Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy

Detalles Bibliográficos
Autores principales: Guerzoni, Simona, Pellesi, Lanfranco, Baraldi, Carlo, Cainazzo, Michela Maria, Negro, Andrea, Martelletti, Paolo, Pini, Luigi Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090896/
http://dx.doi.org/10.3389/fneur.2018.00641
_version_ 1783347284044414976
author Guerzoni, Simona
Pellesi, Lanfranco
Baraldi, Carlo
Cainazzo, Michela Maria
Negro, Andrea
Martelletti, Paolo
Pini, Luigi Alberto
author_facet Guerzoni, Simona
Pellesi, Lanfranco
Baraldi, Carlo
Cainazzo, Michela Maria
Negro, Andrea
Martelletti, Paolo
Pini, Luigi Alberto
author_sort Guerzoni, Simona
collection PubMed
description
format Online
Article
Text
id pubmed-6090896
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60908962018-08-21 Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy Guerzoni, Simona Pellesi, Lanfranco Baraldi, Carlo Cainazzo, Michela Maria Negro, Andrea Martelletti, Paolo Pini, Luigi Alberto Front Neurol Neurology Frontiers Media S.A. 2018-08-07 /pmc/articles/PMC6090896/ http://dx.doi.org/10.3389/fneur.2018.00641 Text en Copyright © 2018 Guerzoni, Pellesi, Baraldi, Cainazzo, Negro, Martelletti and Pini. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Guerzoni, Simona
Pellesi, Lanfranco
Baraldi, Carlo
Cainazzo, Michela Maria
Negro, Andrea
Martelletti, Paolo
Pini, Luigi Alberto
Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
title Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
title_full Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
title_fullStr Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
title_full_unstemmed Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
title_short Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
title_sort addendum: long-term treatment benefits and prolonged efficacy of onabotulinumtoxina in patients affected by chronic migraine and medication overuse headache over 3 years of therapy
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090896/
http://dx.doi.org/10.3389/fneur.2018.00641
work_keys_str_mv AT guerzonisimona addendumlongtermtreatmentbenefitsandprolongedefficacyofonabotulinumtoxinainpatientsaffectedbychronicmigraineandmedicationoveruseheadacheover3yearsoftherapy
AT pellesilanfranco addendumlongtermtreatmentbenefitsandprolongedefficacyofonabotulinumtoxinainpatientsaffectedbychronicmigraineandmedicationoveruseheadacheover3yearsoftherapy
AT baraldicarlo addendumlongtermtreatmentbenefitsandprolongedefficacyofonabotulinumtoxinainpatientsaffectedbychronicmigraineandmedicationoveruseheadacheover3yearsoftherapy
AT cainazzomichelamaria addendumlongtermtreatmentbenefitsandprolongedefficacyofonabotulinumtoxinainpatientsaffectedbychronicmigraineandmedicationoveruseheadacheover3yearsoftherapy
AT negroandrea addendumlongtermtreatmentbenefitsandprolongedefficacyofonabotulinumtoxinainpatientsaffectedbychronicmigraineandmedicationoveruseheadacheover3yearsoftherapy
AT martellettipaolo addendumlongtermtreatmentbenefitsandprolongedefficacyofonabotulinumtoxinainpatientsaffectedbychronicmigraineandmedicationoveruseheadacheover3yearsoftherapy
AT piniluigialberto addendumlongtermtreatmentbenefitsandprolongedefficacyofonabotulinumtoxinainpatientsaffectedbychronicmigraineandmedicationoveruseheadacheover3yearsoftherapy